Anlotinib Recruiting Phase N/A Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03929965Anlotinib in Advanced Solid Tumors With FGFR Alteration